United States First Circuit
In Re: Boston Scientific Corp. Securities Litigation, 11-2250
In a class action on behalf of a proposed class of shareholders of a large publicly traded company that makes and sells medical devices, alleging securities fraud under the Private Securities Litigation Reform Act of 1995 (PLSRA), dismissal of the action is affirmed where on the pleadings, there is clearly insufficient basis to find materiality as to all but the last of the statements at issue or infer scienter as to the last.
Appellate Information
- Decided 07/12/2012
- Published 07/12/2012
Judges
- BOUDIN
Court
- United States First Circuit